| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.8 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.8 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.8 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.024 | 0.8 |